{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:29:56Z","timestamp":1790890196627,"version":"4.1.0"},"reference-count":136,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T00:00:00Z","timestamp":1633996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1007\/s11064-021-03464-1","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T22:11:29Z","timestamp":1634076689000},"page":"234-248","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Dopaminergic Axons: Key Recitalists in Parkinson\u2019s Disease"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0675-0430","authenticated-orcid":false,"given":"Abhishek Kumar","family":"Mishra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubhuti","family":"Dixit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,12]]},"reference":[{"issue":"1","key":"3464_CR1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.neuron.2012.09.023","volume":"76","author":"NX Tritsch","year":"2012","unstructured":"Tritsch NX, Sabatini BL (2012) Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76(1):33\u201350. https:\/\/doi.org\/10.1016\/j.neuron.2012.09.023","journal-title":"Neuron"},{"issue":"2","key":"3464_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.4172\/2471-271x.1000120","volume":"2","author":"G Ayano","year":"2016","unstructured":"Ayano G (2016) Dopamine: receptors, functions, synthesis, pathways, locations and mental disorders: review of literatures. J Ment Disord Treat 2(2):120. https:\/\/doi.org\/10.4172\/2471-271x.1000120","journal-title":"J Ment Disord Treat"},{"issue":"1","key":"3464_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3233\/jpd-150769","volume":"6","author":"P Tagliaferro","year":"2016","unstructured":"Tagliaferro P, Burke RE (2016) Retrograde axonal degeneration in Parkinson disease. J Parkinsons Dis 6(1):1\u201315. https:\/\/doi.org\/10.3233\/jpd-150769","journal-title":"J Parkinsons Dis"},{"key":"3464_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1111\/jnc.14308","volume":"144","author":"J Zhang","year":"2018","unstructured":"Zhang J, Culp ML, Craver JG, Darley-Usmar V (2018) Mitochondrial function and autophagy: integrating proteotoxic, redox, and metabolic stress in Parkinson\u2019s disease. J Neurochem 144:691\u2013709. https:\/\/doi.org\/10.1111\/jnc.14308","journal-title":"J Neurochem"},{"issue":"4","key":"3464_CR5","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1007\/s12640-019-00014-0","volume":"35","author":"A McCormack","year":"2019","unstructured":"McCormack A, Keating DJ, Chegeni N, Colella A, Wang JJ, Chataway T (2019) Abundance of synaptic vesicle-related proteins in alpha-synuclein-containing protein inclusions suggests a targeted formation mechanism. Neurotox Res 35(4):883\u2013897. https:\/\/doi.org\/10.1007\/s12640-019-00014-0","journal-title":"Neurotox Res"},{"key":"3464_CR6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.pneurobio.2013.10.004","volume":"112","author":"S Ghavami","year":"2014","unstructured":"Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W, Moghadam AR, Kashani HH, Hashemi M, Owji AA, \u0141os MJ (2014) Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 112:24\u201349. https:\/\/doi.org\/10.1016\/j.pneurobio.2013.10.004","journal-title":"Prog Neurobiol"},{"issue":"1","key":"3464_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1186\/s13041-019-0504-x","volume":"12","author":"BR Malik","year":"2019","unstructured":"Malik BR, Maddison DC, Smith GA, Peters OM (2019) Autophagic and endo-lysosomal dysfunction in neurodegenerative disease. Mol Brain 12(1):100. https:\/\/doi.org\/10.1186\/s13041-019-0504-x","journal-title":"Mol Brain"},{"issue":"19","key":"3464_CR8","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1111\/febs.14607","volume":"285","author":"DJ Surmeier","year":"2018","unstructured":"Surmeier DJ (2018) Determinants of dopaminergic neuron loss in Parkinson\u2019s disease. FEBS J 285(19):3657\u20133668. https:\/\/doi.org\/10.1111\/febs.14607","journal-title":"FEBS J"},{"issue":"4","key":"3464_CR9","doi-asserted-by":"publisher","first-page":"9","DOI":"10.17116\/patol20188049","volume":"80","author":"DN Voronkov","year":"2018","unstructured":"Voronkov DN, Salkov VN, Anufriev PL, Khudoerkov RM (2018) Lewy bodies in Parkinson\u2019s disease: histological, immunohistochemical and interferometric examinations. Arkh Patol 80(4):9\u201313. https:\/\/doi.org\/10.17116\/patol20188049","journal-title":"Arkh Patol"},{"issue":"30","key":"3464_CR10","doi-asserted-by":"publisher","first-page":"7813","DOI":"10.1073\/pnas.1713129115","volume":"115","author":"I Prots","year":"2018","unstructured":"Prots I, Grosch J, Brazdis RM, Simmnacher K, Veber V, Havlicek S, Hannappel C, Krach F, Krumbiegel M, Sch\u00fctz O, Reis A, Wrasidlo W, Galasko DR, Groemer TW, Masliah E, Schl\u00f6tzer-Schrehardt U, Xiang W, Winkler J, Winner B (2018) \u03b1-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies. Proc Natl Acad Sci U S A 115(30):7813\u20137818. https:\/\/doi.org\/10.1073\/pnas.1713129115","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"3464_CR11","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1002\/mds.25135","volume":"27","author":"JP Bolam","year":"2012","unstructured":"Bolam JP, Pissadaki EK (2012) Living on the edge with too many mouths to feed: why dopamine neurons die. Mov Disord 27(12):1478\u20131483. https:\/\/doi.org\/10.1002\/mds.25135","journal-title":"Mov Disord"},{"issue":"18","key":"3464_CR12","doi-asserted-by":"publisher","first-page":"2349","DOI":"10.1016\/j.cub.2015.07.050","volume":"25","author":"C Pacelli","year":"2015","unstructured":"Pacelli C, Gigu\u00e8re N, Bourque MJ, L\u00e9vesque M, Slack RS, Trudeau L\u00c9 (2015) Elevated mitochondrial bioenergetics and axonal arborization size are key contributors to the vulnerability of dopamine neurons. Curr Biol 25(18):2349\u20132360. https:\/\/doi.org\/10.1016\/j.cub.2015.07.050","journal-title":"Curr Biol"},{"issue":"18","key":"3464_CR13","doi-asserted-by":"publisher","first-page":"R797","DOI":"10.1016\/j.cub.2015.07.062","volume":"25","author":"S Franco-Iborra","year":"2015","unstructured":"Franco-Iborra S, Perier C (2015) Neurodegeneration: the size takes it all. Curr Biol 25(18):R797\u2013R800. https:\/\/doi.org\/10.1016\/j.cub.2015.07.062","journal-title":"Curr Biol"},{"issue":"1","key":"3464_CR14","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40120-018-0091-2","volume":"7","author":"M Mamelak","year":"2018","unstructured":"Mamelak M (2018) Parkinson\u2019s disease, the dopaminergic neuron and gammahydroxybutyrate. Neurol Ther 7(1):5\u201311. https:\/\/doi.org\/10.1007\/s40120-018-0091-2","journal-title":"Neurol Ther"},{"key":"3464_CR15","doi-asserted-by":"publisher","first-page":"930","DOI":"10.3389\/fnins.2019.00930","volume":"13","author":"D Valdinocci","year":"2019","unstructured":"Valdinocci D, Sim\u00f5es RF, Kovarova J, Cunha-Oliveira T, Neuzil J, Pountney DL (2019) Intracellular and intercellular mitochondrial dynamics in Parkinson\u2019s disease. Front Neurosci 13:930. https:\/\/doi.org\/10.3389\/fnins.2019.00930","journal-title":"Front Neurosci"},{"key":"3464_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.semcdb.2019.07.010","volume":"99","author":"W Guo","year":"2020","unstructured":"Guo W, Stoklund Dittlau K, Van Den Bosch L (2020) Axonal transport defects and neurodegeneration: molecular mechanisms and therapeutic implications. Semin Cell Dev Biol 99:133\u2013150. https:\/\/doi.org\/10.1016\/j.semcdb.2019.07.010","journal-title":"Semin Cell Dev Biol"},{"key":"3464_CR17","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fnagi.2020.00100","volume":"12","author":"A Scorziello","year":"2020","unstructured":"Scorziello A, Borzacchiello D, Sisalli MJ, Di Martino R, Morelli M, Feliciello A (2020) Mitochondrial homeostasis and signaling in Parkinson\u2019s disease. Front Aging Neurosci 12:100. https:\/\/doi.org\/10.3389\/fnagi.2020.00100","journal-title":"Front Aging Neurosci"},{"key":"3464_CR18","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3389\/fnsyn.2010.00139","volume":"2","author":"M Vos","year":"2010","unstructured":"Vos M, Lauwers E, Verstreken P (2010) Synaptic mitochondria in synaptic transmission and organization of vesicle pools in health and disease. Front Synaptic Neurosci 2:139. https:\/\/doi.org\/10.3389\/fnsyn.2010.00139","journal-title":"Front Synaptic Neurosci"},{"key":"3464_CR19","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.neulet.2017.08.044","volume":"663","author":"MHR Ludtmann","year":"2018","unstructured":"Ludtmann MHR, Abramov AY (2018) Mitochondrial calcium imbalance in Parkinson\u2019s disease. Neurosci Lett 663:86\u201390. https:\/\/doi.org\/10.1016\/j.neulet.2017.08.044","journal-title":"Neurosci Lett"},{"issue":"1","key":"3464_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41531-018-0044-6","volume":"4","author":"AK Reeve","year":"2018","unstructured":"Reeve AK, Grady JP, Cosgrave EM, Bennison E, Chen C, Hepplewhite PD, Morris CM (2018) Mitochondrial dysfunction within the synapses of substantia nigra neurons in Parkinson\u2019s disease. NPJ Parkinsons Dis 4(1):1\u201310. https:\/\/doi.org\/10.1038\/s41531-018-0044-6","journal-title":"NPJ Parkinsons Dis"},{"issue":"2","key":"3464_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/emmm.200900006","volume":"1","author":"VA Morais","year":"2009","unstructured":"Morais VA, Verstreken P, Roethig A, Smet J, Snellinx A, Vanbrabant M, Haddad D, Frezza C, Mandemakers W, Vogt-Weisenhorn D, Van Coster R, Wurst W, Scorrano L, De Strooper B (2009) Parkinson\u2019s disease mutations in PINK1 result in decreased Complex I activity and deficient synaptic function. EMBO Mol Med 1(2):99\u2013111. https:\/\/doi.org\/10.1002\/emmm.200900006","journal-title":"EMBO Mol Med"},{"key":"3464_CR22","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.bbadis.2013.03.019","volume":"8","author":"A Dixit","year":"1832","unstructured":"Dixit A, Srivastava G, Verma D, Mishra M, Singh PK, Prakash O (1832) Singh MP (2013) Minocycline, levodopa and MnTMPyP induced changes in the mitochondrial proteome profile of MPTP and Maneb and Paraquat mice models of Parkinson\u2019s disease. Biochim Biophys Acta 8:1227\u20131240. https:\/\/doi.org\/10.1016\/j.bbadis.2013.03.019","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"3464_CR23","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1083\/jcb.201302040","volume":"202","author":"Y Chen","year":"2013","unstructured":"Chen Y, Sheng ZH (2013) Kinesin-1-syntaphilin coupling mediates activity-dependent regulation of axonal mitochondrial transport. J Cell Biol 202(2):351\u2013364. https:\/\/doi.org\/10.1083\/jcb.201302040","journal-title":"J Cell Biol"},{"issue":"2","key":"3464_CR24","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3390\/biology8020038","volume":"8","author":"C Chen","year":"2019","unstructured":"Chen C, Turnbull DM, Reeve AK (2019) Mitochondrial dysfunction in Parkinson\u2019s disease\u2014cause or consequence? Biology (Basel) 8(2):38. https:\/\/doi.org\/10.3390\/biology8020038","journal-title":"Biology (Basel)"},{"issue":"3","key":"3464_CR25","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1007\/s12035-014-8954-8","volume":"52","author":"S Agrawal","year":"2015","unstructured":"Agrawal S, Dixit A, Singh A, Tripathi P, Singh D, Patel DK, Singh MP (2015) Cyclosporine A and MnTMPyP alleviate \u03b1-synuclein expression and aggregation in cypermethrin-induced Parkinsonism. Mol Neurobiol 52(3):1619\u20131628. https:\/\/doi.org\/10.1007\/s12035-014-8954-8","journal-title":"Mol Neurobiol"},{"issue":"5","key":"3464_CR26","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.1007\/s12035-015-9124-3","volume":"53","author":"ur Rasheed MS, Tripathi MK, Mishra","year":"2016","unstructured":"ur Rasheed MS, Tripathi MK, Mishra AK, Shukla S, Singh MP, (2016) Resveratrol protects from toxin-induced parkinsonism: plethora of proofs hitherto petty translational value. Mol Neurobiol 53(5):2751\u20132760. https:\/\/doi.org\/10.1007\/s12035-015-9124-3","journal-title":"Mol Neurobiol"},{"key":"3464_CR27","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.ebiom.2019.09.015","volume":"48","author":"P Podlesniy","year":"2019","unstructured":"Podlesniy P, Puigr\u00f2s M, Serra N, Fern\u00e1ndez-Santiago R, Ezquerra M, Tolosa E, Trullas R (2019) Accumulation of mitochondrial 7S DNA in idiopathic and LRRK2 associated Parkinson\u2019s disease. EBioMedicine 48:554\u2013567. https:\/\/doi.org\/10.1016\/j.ebiom.2019.09.015","journal-title":"EBioMedicine"},{"issue":"1","key":"3464_CR28","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/metabo10010019","volume":"10","author":"G Dossi","year":"2019","unstructured":"Dossi G, Squarcina L, Rango M (2019) In vivo mitochondrial function in idiopathic and genetic Parkinson\u2019s disease. Metabolites 10(1):19. https:\/\/doi.org\/10.3390\/metabo10010019","journal-title":"Metabolites"},{"issue":"6","key":"3464_CR29","doi-asserted-by":"publisher","first-page":"1016","DOI":"10.1002\/ana.25099","volume":"82","author":"AG Bury","year":"2017","unstructured":"Bury AG, Pyle A, Elson JL, Greaves L, Morris CM, Hudson G, Pienaar IS (2017) Mitochondrial DNA changes in pedunculopontine cholinergic neurons in Parkinson disease. Ann Neurol 82(6):1016\u20131021. https:\/\/doi.org\/10.1002\/ana.25099","journal-title":"Ann Neurol"},{"issue":"3","key":"3464_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-017-1794-7","volume":"135","author":"IH Fl\u00f8nes","year":"2018","unstructured":"Fl\u00f8nes IH, Fernandez-Vizarra E, Lykouri M, Brakedal B, Skeie GO, Miletic H, Lilleng PK, Alves G, Tysnes OB, Haugarvoll K, D\u00f6lle C, Zeviani M, Tzoulis C (2018) Neuronal complex I deficiency occurs throughout the Parkinson\u2019s disease brain, but is not associated with neurodegeneration or mitochondrial DNA damage. Acta Neuropathol (Berl) 135(3):409\u2013425. https:\/\/doi.org\/10.1007\/s00401-017-1794-7","journal-title":"Acta Neuropathol (Berl)"},{"issue":"7","key":"3464_CR31","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1007\/s10571-019-00700-9","volume":"39","author":"A Dixit","year":"2019","unstructured":"Dixit A, Mehta R, Singh AK (2019) Proteomics in human Parkinson\u2019s disease: present scenario and future directions. Cell Mol Neurobiol 39(7):901\u2013915. https:\/\/doi.org\/10.1007\/s10571-019-00700-9","journal-title":"Cell Mol Neurobiol"},{"issue":"6","key":"3464_CR32","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1111\/jnc.12686","volume":"129","author":"J Segura-Aguilar","year":"2014","unstructured":"Segura-Aguilar J, Paris I, Mu\u00f1oz P, Ferrari E, Zecca L, Zucca FA (2014) Protective and toxic roles of dopamine in Parkinson\u2019s disease. J Neurochem 129(6):898\u2013915. https:\/\/doi.org\/10.1111\/jnc.12686","journal-title":"J Neurochem"},{"key":"3464_CR33","doi-asserted-by":"publisher","first-page":"40699","DOI":"10.1038\/srep40699","volume":"7","author":"N Plotegher","year":"2017","unstructured":"Plotegher N, Berti G, Ferrari E, Tessari I, Zanetti M, Lunelli L, Greggio E, Bisaglia M, Veronesi M, Girotto S, Dalla Serra M, Perego C, Casella L, Bubacco L (2017) DOPAL derived alpha-synuclein oligomers impair synaptic vesicles physiological function. Sci Rep 7:40699. https:\/\/doi.org\/10.1038\/srep40699","journal-title":"Sci Rep"},{"issue":"1","key":"3464_CR34","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","volume":"39","author":"MO Klein","year":"2019","unstructured":"Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG (2019) Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol 39(1):31\u201359. https:\/\/doi.org\/10.1007\/s10571-018-0632-3","journal-title":"Cell Mol Neurobiol"},{"issue":"2","key":"3464_CR35","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1523\/jneurosci.16-02-00436.1996","volume":"16","author":"MJ Nirenberg","year":"1996","unstructured":"Nirenberg MJ, Vaughan RA, Uhl GR, Kuhar MJ, Pickel VM (1996) The dopamine transporter is localized to dendritic and axonal plasma membranes of nigrostriatal dopaminergic neurons. J Neurosci 16(2):436\u2013447. https:\/\/doi.org\/10.1523\/jneurosci.16-02-00436.1996","journal-title":"J Neurosci"},{"issue":"2","key":"3464_CR36","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1002\/(sici)1096-9861(19971117)388:2<211::aid-cne3>3.0.co;2-4","volume":"388","author":"SM Hersch","year":"1997","unstructured":"Hersch SM, Yi H, Heilman CJ, Edwards RH, Levey AI (1997) Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra. J Comp Neurol 388(2):211\u2013227. https:\/\/doi.org\/10.1002\/(sici)1096-9861(19971117)388:2%3c211::aid-cne3%3e3.0.co;2-4","journal-title":"J Comp Neurol"},{"key":"3464_CR37","doi-asserted-by":"publisher","unstructured":"Segura-Aguilar J, Paris I (2014) Mechanisms of dopamine oxidation and parkinson's disease. In: Handbook of neurotoxicity, vol 2, pp 865\u2013883. Springer, New York. https:\/\/doi.org\/10.1007\/978-1-4614-5836-4_16","DOI":"10.1007\/978-1-4614-5836-4_16"},{"issue":"4","key":"3464_CR38","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1124\/pr.114.010397","volume":"67","author":"CL German","year":"2015","unstructured":"German CL, Baladi MG, McFadden LM, Hanson GR, Fleckenstein AE (2015) Regulation of the dopamine and vesicular monoamine transporters: pharmacological targets and implications for disease. Pharmacol Rev 67(4):1005\u20131024. https:\/\/doi.org\/10.1124\/pr.114.010397","journal-title":"Pharmacol Rev"},{"issue":"11 SUPPL. 6","key":"3464_CR39","doi-asserted-by":"publisher","first-page":"S62","DOI":"10.1212\/01.wnl.0000095215.97585.59","volume":"61","author":"N Castagnoli","year":"2003","unstructured":"Castagnoli N, Petzer JP, Steyn S, Castagnoli K, Chen JF, Schwarzschild MA, Van Der Schyf CJ (2003) Monoamine oxidase B inhibition and neuroprotection: studies on selective adenosine A2A receptor antagonists. Neurology 61(11 SUPPL. 6):S62-68. https:\/\/doi.org\/10.1212\/01.wnl.0000095215.97585.59","journal-title":"Neurology"},{"issue":"6","key":"3464_CR40","doi-asserted-by":"publisher","first-page":"897","DOI":"10.4103\/1673-5374.208560","volume":"12","author":"J Segura-Aguilar","year":"2017","unstructured":"Segura-Aguilar J (2017) On the role of endogenous neurotoxins and neuroprotection in Parkinson\u2019s disease. Neural Regen Res 12(6):897\u2013901. https:\/\/doi.org\/10.4103\/1673-5374.208560","journal-title":"Neural Regen Res"},{"issue":"2","key":"3464_CR41","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.neurobiolaging.2010.02.018","volume":"33","author":"AK Singh","year":"2012","unstructured":"Singh AK, Tiwari MN, Upadhyay G, Patel DK, Singh D, Prakash O, Singh MP (2012) Long term exposure to cypermethrin induces nigrostriatal dopaminergic neurodegeneration in adult rats: postnatal exposure enhances the susceptibility during adulthood. Neurobiol Aging 33(2):404\u2013415. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.02.018","journal-title":"Neurobiol Aging"},{"key":"3464_CR42","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/jnc.13696","volume":"139","author":"D Toulorge","year":"2016","unstructured":"Toulorge D, Schapira AHV, Hajj R (2016) Molecular changes in the postmortem parkinsonian brain. J Neurochem 139:27\u201358. https:\/\/doi.org\/10.1111\/jnc.13696","journal-title":"J Neurochem"},{"issue":"6357","key":"3464_CR43","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1126\/science.aam9080","volume":"357","author":"LF Burbulla","year":"2017","unstructured":"Burbulla LF, Song P, Mazzulli JR, Zampese E, Wong YC, Jeon S, Santos DP, Blanz J, Obermaier CD, Strojny C, Savas JN, Kiskinis E, Zhuang X, Kr\u00fcger R, Surmeier DJ, Krainc D (2017) Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson\u2019s disease. Science 357(6357):1255\u20131261. https:\/\/doi.org\/10.1126\/science.aam9080","journal-title":"Science"},{"issue":"11","key":"3464_CR44","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.1523\/jneurosci.5427-08.2009","volume":"29","author":"CY Chung","year":"2009","unstructured":"Chung CY, Koprich JB, Siddiqi H, Isacson O (2009) Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV \u03b1-synucleinopathy. J Neurosci 29(11):3365\u20133373. https:\/\/doi.org\/10.1523\/jneurosci.5427-08.2009","journal-title":"J Neurosci"},{"issue":"3","key":"3464_CR45","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00018-016-2351-6","volume":"74","author":"L Pellegrini","year":"2017","unstructured":"Pellegrini L, Wetzel A, Grann\u00f3 S, Heaton G, Harvey K (2017) Back to the tubule: microtubule dynamics in Parkinson\u2019s disease. Cell Mol Life Sci 74(3):409\u2013434. https:\/\/doi.org\/10.1007\/s00018-016-2351-6","journal-title":"Cell Mol Life Sci"},{"key":"3464_CR46","doi-asserted-by":"publisher","first-page":"6762","DOI":"10.1007\/s12035-016-0188-5","volume":"54","author":"D Cartelli","year":"2017","unstructured":"Cartelli D, Cappelletti G (2017) Microtubule destabilization paves the way to Parkinson\u2019s disease. Mol Neurobiol 54:6762\u20136774. https:\/\/doi.org\/10.1007\/s12035-016-0188-5","journal-title":"Mol Neurobiol"},{"key":"3464_CR47","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.nbd.2017.04.010","volume":"105","author":"ST Brady","year":"2017","unstructured":"Brady ST, Morfini GA (2017) Regulation of motor proteins, axonal transport deficits and adult-onset neurodegenerative diseases. Neurobiol Dis 105:273\u2013282. https:\/\/doi.org\/10.1016\/j.nbd.2017.04.010","journal-title":"Neurobiol Dis"},{"key":"3464_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.mito.2020.10.005","volume":"56","author":"K Panchal","year":"2021","unstructured":"Panchal K, Tiwari AK (2021) Miro (Mitochondrial Rho GTPase), a key player of mitochondrial axonal transport and mitochondrial dynamics in neurodegenerative diseases. Mitochondrion 56:118\u2013135. https:\/\/doi.org\/10.1016\/j.mito.2020.10.005","journal-title":"Mitochondrion"},{"issue":"7","key":"3464_CR49","doi-asserted-by":"publisher","first-page":"2058","DOI":"10.1093\/brain\/aws133","volume":"135","author":"Y Chu","year":"2012","unstructured":"Chu Y, Morfini GA, Langhamer LB, He Y, Brady ST, Kordower JH (2012) Alterations in axonal transport motor proteins in sporadic and experimental Parkinson\u2019s disease. Brain 135(7):2058\u20132073. https:\/\/doi.org\/10.1093\/brain\/aws133","journal-title":"Brain"},{"issue":"8","key":"3464_CR50","doi-asserted-by":"publisher","first-page":"2419","DOI":"10.1093\/brain\/awt192","volume":"136","author":"JH Kordower","year":"2013","unstructured":"Kordower JH, Olanow CW, Dodiya HB, Chu Y, Beach TG, Adler CH, Halliday GM, Bartus RT (2013) Disease duration and the integrity of the nigrostriatal system in Parkinson\u2019s disease. Brain 136(8):2419\u20132431. https:\/\/doi.org\/10.1093\/brain\/awt192","journal-title":"Brain"},{"issue":"41","key":"3464_CR51","doi-asserted-by":"publisher","first-page":"12776","DOI":"10.1523\/jneurosci.3463-09.2009","volume":"29","author":"GA Morfini","year":"2009","unstructured":"Morfini GA, Burns M, Binder LI, Kanaan NM, Lapointe N, Bosco DA, Brown RH, Brown H, Tiwari A, Hayward L, Edgar J, Nave KA, Garberrn J, Atagi Y, Song Y, Pigino G, Brady ST (2009) Axonal transport defects in neurodegenerative diseases. J Neurosci 29(41):12776\u201312786. https:\/\/doi.org\/10.1523\/jneurosci.3463-09.2009","journal-title":"J Neurosci"},{"issue":"7","key":"3464_CR52","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1073\/pnas.0611231104","volume":"104","author":"G Morfini","year":"2007","unstructured":"Morfini G, Pigino G, Opalach K, Serulle Y, Moreira JE, Sugimori M, Llin\u00e1s RR, Brady ST (2007) 1-Methyl-4-phenylpyridinium affects fast axonal transport by activation of caspase and protein kinase C. Proc Natl Acad Sci U S A 104(7):2442\u20132447. https:\/\/doi.org\/10.1073\/pnas.0611231104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"30","key":"3464_CR53","doi-asserted-by":"publisher","first-page":"21742","DOI":"10.1074\/jbc.M113.451815","volume":"288","author":"I Prots","year":"2013","unstructured":"Prots I, Veber V, Brey S, Campioni S, Buder K, Riek R, B\u00f6hm KJ, Winner B (2013) \u03b1-Synuclein oligomers impair neuronal microtubule-kinesin interplay. J Biol Chem 288(30):21742\u201321754. https:\/\/doi.org\/10.1074\/jbc.M113.451815","journal-title":"J Biol Chem"},{"key":"3464_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2019.109399","volume":"133","author":"M-J da Cruz","year":"2019","unstructured":"da Cruz M-J (2019) Hyper-serotonergic state determines onset and progression of idiopathic Parkinson\u2019s disease. Med Hypotheses 133:109399. https:\/\/doi.org\/10.1016\/j.mehy.2019.109399","journal-title":"Med Hypotheses"},{"issue":"4","key":"3464_CR55","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1242\/jcs.171017","volume":"130","author":"KH Flippo","year":"2017","unstructured":"Flippo KH, Strack S (2017) Mitochondrial dynamics in neuronal injury, development and plasticity. J Cell Sci 130(4):671\u2013681. https:\/\/doi.org\/10.1242\/jcs.171017","journal-title":"J Cell Sci"},{"key":"3464_CR56","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.gde.2017.01.016","volume":"44","author":"AJ Whitworth","year":"2017","unstructured":"Whitworth AJ, Pallanck LJ (2017) PINK1\/Parkin mitophagy and neurodegeneration\u2014what do we really know in vivo? Curr Opin Genet Dev 44:47\u201353. https:\/\/doi.org\/10.1016\/j.gde.2017.01.016","journal-title":"Curr Opin Genet Dev"},{"key":"3464_CR57","doi-asserted-by":"publisher","first-page":"3702","DOI":"10.1016\/j.febslet.2015.10.021","volume":"589","author":"D Haddad","year":"2015","unstructured":"Haddad D, Nakamura K (2015) Understanding the susceptibility of dopamine neurons to mitochondrial stressors in Parkinson\u2019s disease. FEBS Lett 589:3702\u20133713. https:\/\/doi.org\/10.1016\/j.febslet.2015.10.021","journal-title":"FEBS Lett"},{"key":"3464_CR58","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.nbd.2016.05.019","volume":"94","author":"P Podlesniy","year":"2016","unstructured":"Podlesniy P, Vilas D, Taylor P, Shaw LM, Tolosa E, Trullas R (2016) Mitochondrial DNA in CSF distinguishes LRRK2 from idiopathic Parkinson\u2019s disease. Neurobiol Dis 94:10\u201317. https:\/\/doi.org\/10.1016\/j.nbd.2016.05.019","journal-title":"Neurobiol Dis"},{"key":"3464_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.bbadis.2009.08.013","volume":"1","author":"KF Winklhofer","year":"1802","unstructured":"Winklhofer KF (1802) Haass C (2010) Mitochondrial dysfunction in Parkinson\u2019s disease. Biochim Biophys Acta 1:29\u201344. https:\/\/doi.org\/10.1016\/j.bbadis.2009.08.013","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"3464_CR60","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1750-1326-9-17","volume":"9","author":"X Lu","year":"2014","unstructured":"Lu X, Kim-Han JS, Harmon S, Sakiyama-Elbert SE, O\u2019Malley KL (2014) The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons. Mol Neurodegener 9(1):17. https:\/\/doi.org\/10.1186\/1750-1326-9-17","journal-title":"Mol Neurodegener"},{"issue":"9","key":"3464_CR61","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1242\/dmm.026294","volume":"10","author":"VM Pozo Devoto","year":"2017","unstructured":"Pozo Devoto VM, Falzone TL (2017) Mitochondrial dynamics in Parkinson\u2019s disease: a role for \u03b1-synuclein? Dis Model Mech 10(9):1075\u20131087. https:\/\/doi.org\/10.1242\/dmm.026294","journal-title":"Dis Model Mech"},{"key":"3464_CR62","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.expneurol.2012.01.011","volume":"246","author":"RE Burke","year":"2013","unstructured":"Burke RE, O\u2019Malley K (2013) Axon degeneration in Parkinson\u2019s disease. Exp Neurol 246:72\u201383. https:\/\/doi.org\/10.1016\/j.expneurol.2012.01.011","journal-title":"Exp Neurol"},{"issue":"5","key":"3464_CR63","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1083\/jcb.201401070","volume":"206","author":"G Ashrafi","year":"2014","unstructured":"Ashrafi G, Schlehe JS, LaVoie MJ, Schwarz TL (2014) Mitophagy of damaged mitochondria occurs locally in distal neuronal axons and requires PINK1 and Parkin. J Cell Biol 206(5):655\u2013670. https:\/\/doi.org\/10.1083\/jcb.201401070","journal-title":"J Cell Biol"},{"issue":"9","key":"3464_CR64","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1089\/ars.2011.4200","volume":"16","author":"A Trancikova","year":"2012","unstructured":"Trancikova A, Tsika E, Moore DJ (2012) Mitochondrial dysfunction in genetic animal models of Parkinson\u2019s disease. Antioxid Redox Signal 16(9):896\u2013919. https:\/\/doi.org\/10.1089\/ars.2011.4200","journal-title":"Antioxid Redox Signal"},{"issue":"5","key":"3464_CR65","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s11910-018-0829-3","volume":"18","author":"JS Park","year":"2018","unstructured":"Park JS, Davis RL, Sue CM (2018) Mitochondrial dysfunction in Parkinson\u2019s disease: new mechanistic insights and therapeutic perspectives. Curr Neurol Neurosci Rep 18(5):21. https:\/\/doi.org\/10.1007\/s11910-018-0829-3","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"3464_CR66","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1242\/jcs.194241","volume":"130","author":"IS Amorim","year":"2017","unstructured":"Amorim IS, Graham LC, Carter RN, Morton NM, Hammachi F, Kunath T, Pennetta G, Carpanini SM, Manson JC, Lamont DJ, Wishart TM, Gillingwater TH (2017) Sideroflexin 3 is an \u03b1-synuclein-dependent mitochondrial protein that regulates synaptic morphology. J Cell Sci 130(2):325\u2013331. https:\/\/doi.org\/10.1242\/jcs.194241","journal-title":"J Cell Sci"},{"issue":"9","key":"3464_CR67","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.3390\/cells8091005","volume":"8","author":"N Mallet","year":"2019","unstructured":"Mallet N, Delgado L, Chazalon M, Miguelez C, Baufreton J (2019) Cellular and synaptic dysfunctions in Parkinson\u2019s disease: stepping out of the striatum. Cells 8(9):1005. https:\/\/doi.org\/10.3390\/cells8091005","journal-title":"Cells"},{"issue":"4","key":"3464_CR68","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/mds.27316","volume":"33","author":"P Fazio","year":"2018","unstructured":"Fazio P, Svenningsson P, Csel\u00e9nyi Z, Halldin C, Farde L, Varrone A (2018) Nigrostriatal dopamine transporter availability in early Parkinson\u2019s disease. Mov Disord 33(4):592\u2013599. https:\/\/doi.org\/10.1002\/mds.27316","journal-title":"Mov Disord"},{"issue":"3","key":"3464_CR69","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1002\/ana.25682","volume":"87","author":"D Matuskey","year":"2020","unstructured":"Matuskey D, Tinaz S, Wilcox KC, Naganawa M, Toyonaga T, Dias M, Henry S, Pittman B, Ropchan J, Nabulsi N, Suridjan I, Comley RA, Huang Y, Finnema SJ, Carson RE (2020) Synaptic changes in Parkinson disease assessed with in vivo imaging. Ann Neurol 87(3):329\u2013338. https:\/\/doi.org\/10.1002\/ana.25682","journal-title":"Ann Neurol"},{"issue":"1","key":"3464_CR70","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s12035-011-8226-9","volume":"45","author":"IS Pienaar","year":"2012","unstructured":"Pienaar IS, Burn D, Morris C, Dexter D (2012) Synaptic protein alterations in Parkinson\u2019s disease. Mol Neurobiol 45(1):126\u2013143. https:\/\/doi.org\/10.1007\/s12035-011-8226-9","journal-title":"Mol Neurobiol"},{"key":"3464_CR71","doi-asserted-by":"publisher","first-page":"699","DOI":"10.3233\/jpd-150642","volume":"5","author":"J Burr\u00e9","year":"2015","unstructured":"Burr\u00e9 J (2015) The synaptic function of \u03b1-synuclein. J Parkinsons Dis 5:699\u2013713. https:\/\/doi.org\/10.3233\/jpd-150642","journal-title":"J Parkinsons Dis"},{"issue":"18","key":"3464_CR72","doi-asserted-by":"publisher","first-page":"e98960","DOI":"10.15252\/embj.201898960","volume":"37","author":"SF Soukup","year":"2018","unstructured":"Soukup SF, Vanhauwaert R, Verstreken P (2018) Parkinson\u2019s disease: convergence on synaptic homeostasis. EMBO J 37(18):e98960. https:\/\/doi.org\/10.15252\/embj.201898960","journal-title":"EMBO J"},{"issue":"2017","key":"3464_CR73","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.nbd.2018.04.020","volume":"122","author":"PY Pan","year":"2019","unstructured":"Pan PY, Zhu Y, Shen Y, Yue Z (2019) Crosstalk between presynaptic trafficking and autophagy in Parkinson\u2019s disease. Neurobiol Dis 122(2017):64\u201371. https:\/\/doi.org\/10.1016\/j.nbd.2018.04.020","journal-title":"Neurobiol Dis"},{"issue":"5\u20136","key":"3464_CR74","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1101\/gad.320077.118","volume":"33","author":"M Shimojo","year":"2019","unstructured":"Shimojo M, Madara J, Pankow S, Liu X, Yates J, S\u00fcdhof TC, Maximov A (2019) Synaptotagmin-11 mediates a vesicle trafficking pathway that is essential for development and synaptic plasticity. Genes Dev 33(5\u20136):365\u2013376. https:\/\/doi.org\/10.1101\/gad.320077.118","journal-title":"Genes Dev"},{"issue":"1","key":"3464_CR75","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41531-017-0008-2","volume":"3","author":"E Bereczki","year":"2017","unstructured":"Bereczki E, Bogstedt A, H\u00f6glund K, Tsitsi P, Brodin L, Ballard C, Svenningsson P, Aarsland D (2017) Synaptic proteins in CSF relate to Parkinson\u2019s disease stage markers. NPJ Parkinsons Dis 3(1):7. https:\/\/doi.org\/10.1038\/s41531-017-0008-2","journal-title":"NPJ Parkinsons Dis"},{"key":"3464_CR76","doi-asserted-by":"publisher","first-page":"80","DOI":"10.3389\/fnins.2018.00080","volume":"12","author":"JC Bridi","year":"2018","unstructured":"Bridi JC, Hirth F (2018) Mechanisms of \u03b1-Synuclein induced synaptopathy in parkinson\u2019s disease. Front Neurosci 12:80. https:\/\/doi.org\/10.3389\/fnins.2018.00080","journal-title":"Front Neurosci"},{"issue":"1","key":"3464_CR77","doi-asserted-by":"publisher","first-page":"6363","DOI":"10.1038\/s41598-017-06724-9","volume":"7","author":"JA Phan","year":"2017","unstructured":"Phan JA, Stokholm K, Zareba-Paslawska J, Jakobsen S, Vang K, Gjedde A, Landau AM, Romero-Ramos M (2017) Early synaptic dysfunction induced by \u03b1-synuclein in a rat model of Parkinson\u2019s disease. Sci Rep 7(1):6363. https:\/\/doi.org\/10.1038\/s41598-017-06724-9","journal-title":"Sci Rep"},{"key":"3464_CR78","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/2051-5960-1-2","volume":"1","author":"NP Visanji","year":"2014","unstructured":"Visanji NP, Brooks PL, Hazrati LN, Lang AE (2014) The prion hypothesis in Parkinson\u2019s disease: Braak to the future. Acta Neuropathol Commun 1:2. https:\/\/doi.org\/10.1186\/2051-5960-1-2","journal-title":"Acta Neuropathol Commun"},{"key":"3464_CR79","doi-asserted-by":"publisher","first-page":"5012129","DOI":"10.1155\/2017\/5012129","volume":"2017","author":"F Longhena","year":"2017","unstructured":"Longhena F, Faustini G, Missale C, Pizzi M, Spano P, Bellucci A (2017) The Contribution of \u03b1-synuclein spreading to Parkinson\u2019s disease synaptopathy. Neural Plas 2017:5012129. https:\/\/doi.org\/10.1155\/2017\/5012129","journal-title":"Neural Plas"},{"key":"3464_CR80","doi-asserted-by":"publisher","first-page":"552","DOI":"10.3389\/fnins.2019.00552","volume":"13","author":"J Ma","year":"2019","unstructured":"Ma J, Gao J, Wang J, Xie A (2019) Prion-like mechanisms in Parkinson\u2019s disease. Front Neurosci 13:552. https:\/\/doi.org\/10.3389\/fnins.2019.00552","journal-title":"Front Neurosci"},{"key":"3464_CR81","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3389\/fnins.2017.00248","volume":"11","author":"EL Gorenberg","year":"2017","unstructured":"Gorenberg EL, Chandra SS (2017) The role of co-chaperones in synaptic proteostasis and neurodegenerative disease. Front Neurosci 11:248. https:\/\/doi.org\/10.3389\/fnins.2017.00248","journal-title":"Front Neurosci"},{"key":"3464_CR82","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnmol.2019.00055","volume":"12","author":"C Catoni","year":"2019","unstructured":"Catoni C, Cal\u00ec T, Brini M (2019) Calcium, dopamine and neuronal calcium sensor 1: their contribution to Parkinson\u2019s disease. Front Mol Neurosci 12:55. https:\/\/doi.org\/10.3389\/fnmol.2019.00055","journal-title":"Front Mol Neurosci"},{"issue":"4","key":"3464_CR83","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.bbrc.2016.08.168","volume":"483","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier DJ, Schumacker PT, Guzman JD, Ilijic E, Yang B, Zampese E (2017) Calcium and Parkinson\u2019s disease. Biochem Biophys Res Commun 483(4):1013\u20131019. https:\/\/doi.org\/10.1016\/j.bbrc.2016.08.168","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"3464_CR84","doi-asserted-by":"publisher","first-page":"5094","DOI":"10.1038\/s41467-019-12834-x","volume":"10","author":"J Benkert","year":"2019","unstructured":"Benkert J, Hess S, Roy S, Beccano-Kelly D, Wiederspohn N, Duda J, Simons C, Patil K, Gaifullina A, Mannal N, Dragicevic E, Spaich D, M\u00fcller S, Nemeth J, Hollmann H, Deuter N, Mousba Y, Kubisch C, Poetschke C, Striessnig J, Pongs O, Schneider T, Wade-Martins R, Patel S, Parlato R, Frank T, Kloppenburg P, Liss B (2019) Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson\u2019s disease. Nat Commun 10(1):5094. https:\/\/doi.org\/10.1038\/s41467-019-12834-x","journal-title":"Nat Commun"},{"issue":"5","key":"3464_CR85","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1242\/dmm.028738","volume":"10","author":"SV Zaichick","year":"2017","unstructured":"Zaichick SV, McGrath KM, Caraveo G (2017) The role of Ca2+ signaling in Parkinson\u2019s disease. Dis Model Mech 10(5):519\u2013535. https:\/\/doi.org\/10.1242\/dmm.028738","journal-title":"Dis Model Mech"},{"issue":"8","key":"3464_CR86","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1021\/acschemneuro.9b00325","volume":"10","author":"KR Brimblecombe","year":"2019","unstructured":"Brimblecombe KR, Vietti-Michelina S, Platt NJ, Kastli R, Hnieno A, Gracie CJ, Cragg SJ (2019) Calbindin-D28K limits dopamine release in ventral but not dorsal striatum by regulating Ca2+ availability and dopamine transporter function. ACS Chem Neurosci 10(8):3419\u20133426. https:\/\/doi.org\/10.1021\/acschemneuro.9b00325","journal-title":"ACS Chem Neurosci"},{"key":"3464_CR87","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fnmol.2019.00237","volume":"12","author":"E Leandrou","year":"2019","unstructured":"Leandrou E, Emmanouilidou E, Vekrellis K (2019) Voltage-gated calcium channels and \u03b1-synuclein: implications in Parkinson\u2019s disease. Front Mol Neurosci 12:237. https:\/\/doi.org\/10.3389\/fnmol.2019.00237","journal-title":"Front Mol Neurosci"},{"key":"3464_CR88","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fnagi.2019.00382","volume":"11","author":"A Verma","year":"2020","unstructured":"Verma A, Ravindranath V (2020) CaV1.3 L-type calcium channels increase the vulnerability of substantia nigra dopaminergic neurons in MPTP mouse model of Parkinson\u2019s disease. Front Aging Neurosci 11:382. https:\/\/doi.org\/10.3389\/fnagi.2019.00382","journal-title":"Front Aging Neurosci"},{"key":"3464_CR89","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.neuroscience.2011.08.045","volume":"198","author":"DJ Surmeier","year":"2011","unstructured":"Surmeier DJ, Guzman JN, Sanchez-Padilla J, Schumacker PT (2011) The role of calcium and mitochondrial oxidant stress in the loss of substantia nigra pars compacta dopaminergic neurons in Parkinson\u2019s disease. Neuroscience 198:221\u2013231. https:\/\/doi.org\/10.1016\/j.neuroscience.2011.08.045","journal-title":"Neuroscience"},{"issue":"1","key":"3464_CR90","doi-asserted-by":"publisher","first-page":"4857","DOI":"10.1038\/s41598-019-41091-7","volume":"9","author":"C Sgobio","year":"2019","unstructured":"Sgobio C, Sun L, Ding J, Herms J, Lovinger DM, Cai H (2019) Unbalanced calcium channel activity underlies selective vulnerability of nigrostriatal dopaminergic terminals in Parkinsonian mice. Sci Rep 9(1):4857. https:\/\/doi.org\/10.1038\/s41598-019-41091-7","journal-title":"Sci Rep"},{"issue":"7","key":"3464_CR91","doi-asserted-by":"publisher","first-page":"2077","DOI":"10.1093\/brain\/awt134","volume":"136","author":"MJ Hurley","year":"2013","unstructured":"Hurley MJ, Brandon B, Gentleman SM, Dexter DT (2013) Parkinson\u2019s disease is associated with altered expression of Ca V1 channels and calcium-binding proteins. Brain 136(7):2077\u20132097. https:\/\/doi.org\/10.1093\/brain\/awt134","journal-title":"Brain"},{"key":"3464_CR92","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3389\/fnins.2018.00819","volume":"12","author":"C Betzer","year":"2018","unstructured":"Betzer C, Jensen PH (2018) Reduced cytosolic calcium as an early decisive cellular state in Parkinson\u2019s disease and synucleinopathies. Front Neurosci 12:819. https:\/\/doi.org\/10.3389\/fnins.2018.00819","journal-title":"Front Neurosci"},{"issue":"9","key":"3464_CR93","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1242\/jcs.180737","volume":"129","author":"PR Angelova","year":"2016","unstructured":"Angelova PR, Ludtmann MHR, Horrocks MH, Negoda A, Cremades N, Klenerman D, Dobson CM, Wood NW, Pavlov EV, Gandhi S, Abramov AY (2016) Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity. J Cell Sci 129(9):1792\u20131801. https:\/\/doi.org\/10.1242\/jcs.180737","journal-title":"J Cell Sci"},{"key":"3464_CR94","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3389\/fnins.2018.00523","volume":"12","author":"M Verma","year":"2018","unstructured":"Verma M, Wills Z, Chu CT (2018) Excitatory dendritic mitochondrial calcium toxicity: implications for Parkinson\u2019s and other neurodegenerative diseases. Front Neurosci 12:523. https:\/\/doi.org\/10.3389\/fnins.2018.00523","journal-title":"Front Neurosci"},{"key":"3464_CR95","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3390\/ijms21051772","volume":"21","author":"L Barazzuol","year":"2020","unstructured":"Barazzuol L, Giamogante F, Brini M, Cal\u00ec T (2020) PINK1\/Parkin mediated mitophagy, Ca2+ signalling, and ER-mitochondria contacts in Parkinson\u2019s disease. Int J Mol Sci 21:1772. https:\/\/doi.org\/10.3390\/ijms21051772","journal-title":"Int J Mol Sci"},{"issue":"4","key":"3464_CR96","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.devcel.2015.02.002","volume":"32","author":"J Lim","year":"2015","unstructured":"Lim J, Yue Z (2015) Neuronal aggregates: formation, clearance, and spreading. Dev Cell 32(4):491\u2013501. https:\/\/doi.org\/10.1016\/j.devcel.2015.02.002","journal-title":"Dev Cell"},{"issue":"4","key":"3464_CR97","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.neuron.2011.02.010","volume":"69","author":"D Sulzer","year":"2011","unstructured":"Sulzer D (2011) How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69(4):628\u2013649. https:\/\/doi.org\/10.1016\/j.neuron.2011.02.010","journal-title":"Neuron"},{"issue":"1","key":"3464_CR98","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1021\/cn5002705","volume":"6","author":"CA Siciliano","year":"2015","unstructured":"Siciliano CA, Calipari ES, Ferris MJ, Jones SR (2015) Adaptations of presynaptic dopamine terminals induced by psychostimulant self-administration. ACS Chem Neurosci 6(1):27\u201336. https:\/\/doi.org\/10.1021\/cn5002705","journal-title":"ACS Chem Neurosci"},{"key":"3464_CR99","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.neuropharm.2015.10.025","volume":"101","author":"JT Yorgason","year":"2016","unstructured":"Yorgason JT, Calipari ES, Ferris MJ, Karkhanis AN, Fordahl SC, Weiner JL, Jones SR (2016) Social isolation rearing increases dopamine uptake and psychostimulant potency in the striatum. Neuropharmacology 101:471\u2013479. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.10.025","journal-title":"Neuropharmacology"},{"issue":"6","key":"3464_CR100","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1002\/ana.21995","volume":"67","author":"HC Cheng","year":"2010","unstructured":"Cheng HC, Ulane CM, Burke RE (2010) Clinical progression in Parkinson disease and the neurobiology of axons. Ann Neurol 67(6):715\u2013725. https:\/\/doi.org\/10.1002\/ana.21995","journal-title":"Ann Neurol"},{"issue":"1","key":"3464_CR101","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.expneurol.2006.05.017","volume":"202","author":"DM Hasbani","year":"2006","unstructured":"Hasbani DM, O\u2019Malley KL (2006) WldS mice are protected against the Parkinsonian mimetic MPTP. Exp Neurol 202(1):93\u201399. https:\/\/doi.org\/10.1016\/j.expneurol.2006.05.017","journal-title":"Exp Neurol"},{"issue":"4","key":"3464_CR102","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/j.celrep.2016.09.058","volume":"17","author":"JD Murdoch","year":"2016","unstructured":"Murdoch JD, Rostosky CM, Gowrisankaran S, Arora AS, Soukup SF, Vidal R, Capece V, Freytag S, Fischer A, Verstreken P, Bonn S, Raimundo N, Milosevic I (2016) Endophilin\u2014a deficiency induces the Foxo3a-Fbxo32 network in the brain and causes dysregulation of autophagy and the ubiquitin-proteasome system. Cell Rep 17(4):1071\u20131086. https:\/\/doi.org\/10.1016\/j.celrep.2016.09.058","journal-title":"Cell Rep"},{"key":"3464_CR103","doi-asserted-by":"publisher","unstructured":"Jin EJ, Kiral FR, Ozel MN, Burchardt LS, Osterland M, Epstein D, Wolfenberg H, Prohaska S, Hiesinger PR (2018) Live observation of two parallel membrane degradation pathways at axon terminals. Curr Biol 28 (7):1027\u20131038e1024. https:\/\/doi.org\/10.1016\/j.cub.2018.02.032","DOI":"10.1016\/j.cub.2018.02.032"},{"key":"3464_CR104","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1146\/annurev-cellbio-100818-125242","volume":"35","author":"AKH Stavoe","year":"2019","unstructured":"Stavoe AKH, Holzbaur ELF (2019) Autophagy in neurons. Annu Rev Cell Dev Biol 35:477\u2013500. https:\/\/doi.org\/10.1146\/annurev-cellbio-100818-125242","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"8","key":"3464_CR105","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.parkreldis.2015.06.005","volume":"21","author":"S Olgiati","year":"2015","unstructured":"Olgiati S, Thomas A, Quadri M, Breedveld GJ, Graafland J, Eussen H, Douben H, de Klein A, Onofrj M, Bonifati V (2015) Early-onset Parkinsonism caused by alpha-synuclein gene triplication: clinical and genetic findings in a novel family. Parkinsonism Relat Disord 21(8):981\u2013986. https:\/\/doi.org\/10.1016\/j.parkreldis.2015.06.005","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"3464_CR106","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1042\/bst20120113","volume":"40","author":"S Lee","year":"2012","unstructured":"Lee S, Imai Y, Gehrke S, Liu S, Lu B (2012) The synaptic function of LRRK2. Biochem Soc Trans 40(5):1047\u20131051. https:\/\/doi.org\/10.1042\/bst20120113","journal-title":"Biochem Soc Trans"},{"issue":"3","key":"3464_CR107","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1242\/jcs.158196","volume":"128","author":"AM Arranz","year":"2015","unstructured":"Arranz AM, Delbroek L, van Kolen K, Guimar\u00e3es MR, Mandemakers W, Daneels G, Matta S, Calafate S, Shaban H, Baatsen P, de Bock PJ, Gevaert K, Berghe PV, Verstreken P, de Strooper B, Moechars D (2015) LRRK2 functions in synaptic vesicle endocytosis through a kinase dependent mechanism. J Cell Sci 128(3):541\u2013552. https:\/\/doi.org\/10.1242\/jcs.158196","journal-title":"J Cell Sci"},{"key":"3464_CR108","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/978-3-319-49969-7_9","volume":"14","author":"Y Xiong","year":"2017","unstructured":"Xiong Y, Dawson TM, Dawson VL (2017) Models of LRRK2-associated Parkinson\u2019s disease. Adv Neurobiol 14:163\u2013191. https:\/\/doi.org\/10.1007\/978-3-319-49969-7_9","journal-title":"Adv Neurobiol"},{"key":"3464_CR109","doi-asserted-by":"publisher","first-page":"153","DOI":"10.3389\/fnmol.2020.00153","volume":"13","author":"N Kuhlmann","year":"2020","unstructured":"Kuhlmann N, Milnerwood AJ (2020) A critical LRRK at the synapse? The neurobiological function and pathophysiological dysfunction of LRRK2. Front Mol Neurosci 13:153. https:\/\/doi.org\/10.3389\/fnmol.2020.00153","journal-title":"Front Mol Neurosci"},{"issue":"49","key":"3464_CR110","doi-asserted-by":"publisher","first-page":"16544","DOI":"10.1523\/jneurosci.1710-14.2014","volume":"34","author":"M Cao","year":"2014","unstructured":"Cao M, Milosevic I, Giovedi S, De Camilli P (2014) Upregulation of Parkin in endophilin mutant mice. J Neurosci 34(49):16544\u201316549. https:\/\/doi.org\/10.1523\/jneurosci.1710-14.2014","journal-title":"J Neurosci"},{"issue":"9","key":"3464_CR111","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1093\/brain\/awx006","volume":"140","author":"J Sassone","year":"2017","unstructured":"Sassone J, Serratto GM, Valtorta F, Silani V, Passafaro M, Ciammola A (2017) The synaptic function of Parkin. Brain 140(9):2265\u20132272. https:\/\/doi.org\/10.1093\/brain\/awx006","journal-title":"Brain"},{"key":"3464_CR112","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.5213\/inj.1836216.108","volume":"22","author":"W Lee","year":"2018","unstructured":"Lee W, Koh S, Hwang S, Kim SH (2018) Presynaptic dysfunction by familial factors in Parkinson disease. Int Neurourol J 22:S115\u2013S121. https:\/\/doi.org\/10.5213\/inj.1836216.108","journal-title":"Int Neurourol J"},{"issue":"2","key":"3464_CR113","doi-asserted-by":"publisher","first-page":"219","DOI":"10.3233\/jpd-161020","volume":"7","author":"ET Williams","year":"2017","unstructured":"Williams ET, Chen X, Moore DJ (2017) VPS35, the retromer complex and Parkinson\u2019s disease. J Parkinsons Dis 7(2):219\u2013233. https:\/\/doi.org\/10.3233\/jpd-161020","journal-title":"J Parkinsons Dis"},{"key":"3464_CR114","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.neuroscience.2019.01.006","volume":"401","author":"AA Rahman","year":"2019","unstructured":"Rahman AA, Morrison BE (2019) Contributions of VPS35 mutations to Parkinson\u2019s disease. Neuroscience 401:1\u201310. https:\/\/doi.org\/10.1016\/j.neuroscience.2019.01.006","journal-title":"Neuroscience"},{"key":"3464_CR115","doi-asserted-by":"publisher","first-page":"1272","DOI":"10.3389\/fneur.2019.01272","volume":"10","author":"S Eleuteri","year":"2019","unstructured":"Eleuteri S, Albanese A (2019) VPS35-based approach: a potential innovative treatment in Parkinson\u2019s disease. Front Neurol 10:1272. https:\/\/doi.org\/10.3389\/fneur.2019.01272","journal-title":"Front Neurol"},{"key":"3464_CR116","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/j.nbd.2017.08.001","volume":"108","author":"J Stanic","year":"2017","unstructured":"Stanic J, Mellone M, Napolitano F, Racca C, Zianni E, Minocci D, Ghiglieri V, Thiolat ML, Li Q, Longhi A, De Rosa A, Picconi B, Bezard E, Calabresi P, Di Luca M, Usiello A, Gardoni F (2017) Rabphilin 3A: a novel target for the treatment of levodopa-induced dyskinesias. Neurobiol Dis 108:54\u201364. https:\/\/doi.org\/10.1016\/j.nbd.2017.08.001","journal-title":"Neurobiol Dis"},{"key":"3464_CR117","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fncel.2017.00081","volume":"11","author":"MM Shi","year":"2017","unstructured":"Shi MM, Shi CH, Xu YM (2017) Rab GTPases: the key players in the molecular pathway of Parkinson\u2019s disease. Front Cell Neurosci 11:81. https:\/\/doi.org\/10.3389\/fncel.2017.00081","journal-title":"Front Cell Neurosci"},{"issue":"9","key":"3464_CR118","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.neurol.2018.08.004","volume":"174","author":"A Lunati","year":"2018","unstructured":"Lunati A, Lesage S, Brice A (2018) The genetic landscape of Parkinson\u2019s disease. Rev Neurol (Paris) 174(9):628\u2013643. https:\/\/doi.org\/10.1016\/j.neurol.2018.08.004","journal-title":"Rev Neurol (Paris)"},{"key":"3464_CR119","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-cellbio-100818-125512","volume":"36","author":"PK Singh","year":"2020","unstructured":"Singh PK, Muqit MMK (2020) Parkinson\u2019s: a disease of aberrant vesicle trafficking. Annu Rev Cell Dev Biol 36:237\u2013264. https:\/\/doi.org\/10.1146\/annurev-cellbio-100818-125512","journal-title":"Annu Rev Cell Dev Biol"},{"issue":"5","key":"3464_CR120","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1016\/j.celrep.2017.01.005","volume":"18","author":"L Song","year":"2017","unstructured":"Song L, He Y, Ou J, Zhao Y, Li R, Cheng J, Lin CH, Ho MS (2017) Auxilin underlies progressive locomotor deficits and dopaminergic neuron loss in a Drosophila model of Parkinson\u2019s disease. Cell Rep 18(5):1132\u20131143. https:\/\/doi.org\/10.1016\/j.celrep.2017.01.005","journal-title":"Cell Rep"},{"issue":"21","key":"3464_CR121","doi-asserted-by":"publisher","first-page":"5576","DOI":"10.1073\/pnas.1717590115","volume":"115","author":"M Nguyen","year":"2018","unstructured":"Nguyen M, Krainc D (2018) LRRK2 phosphorylation of auxilin mediates synaptic defects in dopaminergic neurons from patients with Parkinson\u2019s disease. Proc Natl Acad Sci U S A 115(21):5576\u20135581. https:\/\/doi.org\/10.1073\/pnas.1717590115","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3464_CR122","doi-asserted-by":"publisher","DOI":"10.1101\/830802","author":"DA Roosen","year":"2019","unstructured":"Roosen DA, Landeck N, Conti M, Smith N, Saez-Atienzar S, Ding J, Beilina A, Kumaran R, Kaganovich A, Du Hoffmann J (2019) Mutations in Auxilin cause parkinsonism via impaired clathrin-mediated trafficking at the Golgi apparatus and synapse. BioRxiv. https:\/\/doi.org\/10.1101\/830802","journal-title":"BioRxiv"},{"issue":"3","key":"3464_CR123","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41419-018-0410-7","volume":"9","author":"D Fasano","year":"2018","unstructured":"Fasano D, Parisi S, Pierantoni GM, De Rosa A, Picillo M, Amodio G, Pellecchia MT, Barone P, Moltedo O, Bonifati V, De Michele G, Nitsch L, Remondelli P, Criscuolo C, Paladino S (2018) Alteration of endosomal trafficking is associated with early-onset parkinsonism caused by SYNJ1 mutations. Cell Death Dis 9(3):1\u201315. https:\/\/doi.org\/10.1038\/s41419-018-0410-7","journal-title":"Cell Death Dis"},{"issue":"22","key":"3464_CR124","doi-asserted-by":"publisher","first-page":"12428","DOI":"10.1073\/pnas.2004335117","volume":"117","author":"M Cao","year":"2020","unstructured":"Cao M, Park D, Wu Y, De Camilli P (2020) Absence of Sac2\/INPP5F enhances the phenotype of a Parkinson\u2019s disease mutation of synaptojanin 1. Proc Natl Acad Sci U S A 117(22):12428\u201312434. https:\/\/doi.org\/10.1073\/pnas.2004335117","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"3464_CR125","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.tins.2018.11.001","volume":"42","author":"M Nguyen","year":"2019","unstructured":"Nguyen M, Wong YC, Ysselstein D, Severino A, Krainc D (2019) Synaptic, mitochondrial, and lysosomal dysfunction in Parkinson\u2019s disease. Trends Neurosci 42(2):140\u2013149. https:\/\/doi.org\/10.1016\/j.tins.2018.11.001","journal-title":"Trends Neurosci"},{"issue":"5","key":"3464_CR126","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jnc.14820","volume":"150","author":"DJ Vidyadhara","year":"2019","unstructured":"Vidyadhara DJ, Lee JE, Chandra SS (2019) Role of the endolysosomal system in Parkinson\u2019s disease. J Neurochem 150(5):487\u2013506. https:\/\/doi.org\/10.1111\/jnc.14820","journal-title":"J Neurochem"},{"issue":"6","key":"3464_CR127","doi-asserted-by":"publisher","first-page":"4455","DOI":"10.1007\/s12035-018-1386-0","volume":"56","author":"C Agliardi","year":"2019","unstructured":"Agliardi C, Guerini FR, Zanzottera M, Riboldazzi G, Zangaglia R, Sturchio A, Casali C, Di Lorenzo C, Minafra B, Nemni R, Clerici M (2019) SNAP25 gene polymorphisms protect against Parkinson\u2019s disease and modulate disease severity in patients. Mol Neurobiol 56(6):4455\u20134463. https:\/\/doi.org\/10.1007\/s12035-018-1386-0","journal-title":"Mol Neurobiol"},{"issue":"6","key":"3464_CR128","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1111\/bpa.12587","volume":"28","author":"F Longhena","year":"2018","unstructured":"Longhena F, Faustini G, Varanita T, Zaltieri M, Porrini V, Tessari I, Poliani PL, Missale C, Borroni B, Padovani A, Bubacco L, Pizzi M, Spano PF, Bellucci A (2018) Synapsin III is a key component of \u03b1-synuclein fibrils in Lewy bodies of PD brains. Brain Pathol 28(6):875\u2013888. https:\/\/doi.org\/10.1111\/bpa.12587","journal-title":"Brain Pathol"},{"issue":"23","key":"3464_CR129","doi-asserted-by":"publisher","first-page":"11116","DOI":"10.1073\/pnas.1903054116","volume":"166","author":"M Atias","year":"2019","unstructured":"Atias M, Tevet Y, Sun J, Stavsky A, Tal S, Kahn J, Roy S, Gitler D (2019) Synapsins regulate \u03b1-synuclein functions. Proc Natl Acad Sci U S A 166(23):11116\u201311118. https:\/\/doi.org\/10.1073\/pnas.1903054116","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"3464_CR130","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.neuron.2017.01.019","volume":"93","author":"M Cao","year":"2017","unstructured":"Cao M, Wu Y, Ashrafi G, McCartney AJ, Wheeler H, Bushong EA, Boassa D, Ellisman MH, Ryan TA, De Camilli P (2017) Parkinson sac domain mutation in synaptojanin 1 impairs clathrin uncoating at synapses and triggers dystrophic changes in dopaminergic axons. Neuron 93(4):882\u2013896. https:\/\/doi.org\/10.1016\/j.neuron.2017.01.019","journal-title":"Neuron"},{"issue":"1","key":"3464_CR131","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/ncomms11803","volume":"7","author":"CF Bento","year":"2016","unstructured":"Bento CF, Ashkenazi A, Jimenez-Sanchez M, Rubinsztein DC (2016) The Parkinson\u2019s disease-associated genes ATP13A2 and SYT11 regulate autophagy via a common pathway. Nat Commun 7(1):1\u201316. https:\/\/doi.org\/10.1038\/ncomms11803","journal-title":"Nat Commun"},{"issue":"1","key":"3464_CR132","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-017-02593-y","volume":"9","author":"C Wang","year":"2018","unstructured":"Wang C, Kang X, Zhou L, Chai Z, Wu Q, Huang R, Xu H, Hu M, Sun X, Sun S, Li J, Jiao R, Zuo P, Zheng L, Yue Z, Zhou Z (2018) Synaptotagmin-11 is a critical mediator of Parkin-linked neurotoxicity and Parkinson\u2019s disease-like pathology. Nat Commun 9(1):1\u201314. https:\/\/doi.org\/10.1038\/s41467-017-02593-y","journal-title":"Nat Commun"},{"issue":"7","key":"3464_CR133","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/brain\/awq132","volume":"133","author":"P Garcia-Reitb\u00f6ck","year":"2010","unstructured":"Garcia-Reitb\u00f6ck P, Anichtchik O, Bellucci A, Iovino M, Ballini C, Fineberg E, Ghetti B, Della Corte L, Spano P, Tofaris GK, Goedert M, Spillantini MG (2010) SNARE protein redistribution and synaptic failure in a transgenic mouse model of Parkinson\u2019s disease. Brain 133(7):2032\u20132044. https:\/\/doi.org\/10.1093\/brain\/awq132","journal-title":"Brain"},{"key":"3464_CR134","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/1756-6606-6-35","volume":"6","author":"N Ageta-Ishihara","year":"2013","unstructured":"Ageta-Ishihara N, Yamakado H, Morita T, Hattori S, Takao K, Miyakawa T, Takahashi R, Kinoshita M (2013) Chronic overload of SEPT4, a parkin substrate that aggregates in Parkinson\u2019s disease, causes behavioral alterations but not neurodegeneration in mice. Mol Brain 6:35. https:\/\/doi.org\/10.1186\/1756-6606-6-35","journal-title":"Mol Brain"},{"key":"3464_CR135","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.brainres.2013.12.017","volume":"1546","author":"G Sala","year":"2014","unstructured":"Sala G, Stefanoni G, Arosio A, Riva C, Melchionda L, Saracchi E, Fermi S, Brighina L, Ferrarese C (2014) Reduced expression of the chaperone-mediated autophagy carrier hsc70 protein in lymphomonocytes of patients with Parkinson\u2019s disease. Brain Res 1546:46\u201352. https:\/\/doi.org\/10.1016\/j.brainres.2013.12.017","journal-title":"Brain Res"},{"key":"3464_CR136","doi-asserted-by":"publisher","first-page":"157","DOI":"10.3389\/fnmol.2016.00157","volume":"9","author":"G Sala","year":"2016","unstructured":"Sala G, Marinig D, Arosio A, Ferrarese C (2016) Role of chaperone-mediated autophagy dysfunctions in the pathogenesis of Parkinson\u2019s disease. Front Mol Neurosci 9:157. https:\/\/doi.org\/10.3389\/fnmol.2016.00157","journal-title":"Front Mol Neurosci"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-021-03464-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-021-03464-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T06:42:34Z","timestamp":1644388954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-021-03464-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,12]]},"references-count":136,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["3464"],"URL":"https:\/\/doi.org\/10.1007\/s11064-021-03464-1","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,12]]},"assertion":[{"value":"31 May 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors in the manuscript declare that they do not have any conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}